Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIM3 | Q86V86 | 2/20 | 0.41 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | PI4KA | P42356 | 1/20 | 0.36 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.36 |
| ▸ | F9 | P00740 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25645875 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL25645879 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL19802135 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL24231220 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL19802544 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL24216417 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL19802119 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL22329241 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL22140779 | 1.00 | PIM3 (0.41) | PIM3LIMK1ROCK1ADORA2AADORA1 | |
| SCHEMBL22876262 | 0.99 | PIM3 (0.40) | PIM3LIMK1ROCK1ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240023355-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-20240023355-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2024-01-18 | — | — | US | disclosed |
| US-11800730-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11800730-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2023-10-24 | — | — | US | disclosed |
| US-11685859-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11685859-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20210009894-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
| EP-3348625-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG Chem, Ltd. (KR) | 2018-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240023355-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CRY2, CYP1A1 | PIM3 3736/4885LIMK1 258/4885ROCK1 2855/4885 |
| US-11800730-B2 | Organic light emitting device | CRY1, CRY2, MAP1LC3C | PIM3 1569/4885LIMK1 757/4885ROCK1 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.